Citius Pharmaceuticals, Inc. (CTXR)
0.585
-0.02
(-2.82%)
USD |
NASDAQ |
Sep 04, 14:31
Citius Pharmaceuticals Debt to Equity Ratio : 0.1077 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1077 |
| March 31, 2026 | 0.0131 |
| December 31, 2025 | 0.0229 |
| September 30, 2025 | 0.0268 |
| June 30, 2025 | 0.0289 |
| March 31, 2025 | 0.0154 |
| December 31, 2024 | 0.0031 |
| September 30, 2024 | 0.0038 |
| June 30, 2024 | 0.0037 |
| March 31, 2024 | 0.0047 |
| December 31, 2023 | 0.0051 |
| September 30, 2023 | 0.0053 |
| June 30, 2023 | 0.0055 |
| March 31, 2023 | 0.0064 |
| December 31, 2022 | 0.0063 |
| September 30, 2022 | 0.0066 |
| June 30, 2022 | 0.0066 |
| March 31, 2022 | 0.0065 |
| December 31, 2021 | 0.0066 |
| September 30, 2021 | 0.0065 |
| June 30, 2021 | 0.0078 |
| March 31, 2021 | 0.0102 |
| December 31, 2020 | 0.0521 |
| September 30, 2020 | 0.0402 |
| June 30, 2020 | 0.0483 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0562 |
| December 31, 2019 | 0.0636 |
| September 30, 2019 | 0.0071 |
| June 30, 2019 | 0.008 |
| March 31, 2019 | 0.0083 |
| December 31, 2018 | 0.0072 |
| September 30, 2018 | 0.0062 |
| June 30, 2018 | 0.008 |
| March 31, 2018 | 0.0074 |
| December 31, 2017 | 0.0067 |
| September 30, 2017 | 0.0079 |
| June 30, 2017 | 0.4672 |
| March 31, 2017 | 0.1446 |
| December 31, 2016 | 0.0985 |
| September 30, 2016 | 0.0401 |
| June 30, 2016 | 0.0095 |
| March 31, 2016 | 0.0378 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| June 30, 2014 | -0.9299 |
| March 31, 2014 | -0.9641 |
| December 31, 2013 | -1.38 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Citius Oncology, Inc. | 0.2528 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 142.26M |
| Total Liabilities (Quarterly) | 66.35M |
| Shareholders Equity (Quarterly) | 66.61M |
| Current Ratio | 0.839 |
| Net Debt Paydown Yield | -7.53% |